A TKI Update for Wet AMD

Carl D. Regillo, MD and R.V. Paul Chan, MD, MSc, MBA, FACS

Show Description +

Dr. Regillo shares data on several tyrosine kinase inhibitors in the pipeline for the treatment of wet AMD; a few are in phase 3 now.

Posted: 3/12/2025

Keywords:

retina-meeting-recap

•

TKI

•

tyrosine kinase inhibitor (TKI)

•

Wet AMD

•

Age-Related Macular Degeneration (AMD)

•

Clinical Trials

Up Next

Name: A TKI Update for Wet AMD
Uploaded: 2025-03-12T17:45:52+00:00
Description: Dr. Regillo shares data on several tyrosine kinase inhibitors in the pipeline for the treatment of wet AMD; a few are in phase 3 now.

Gene Therapy for IRDs and Other Retinal Diseases

Szilárd Kiss, MD and R.V. Paul Chan, MD, MSc, MBA, FACS

Founders Lecture: Pediatric Retina

Audina M Berrocal, MD; and Timothy G. Murray, MD, MBA

Improving Efficiency in the Clinic and OR

John W. Kitchens, MD; and Timothy G. Murray, MD, MBA

FA vs OCTA in the Retina Clinic

John B. Miller, MD; and R.V. Paul Chan, MD, MSC, MBA, FACS

An Update on 3D Visualization and Intraoperative OCT

Lejla Vajzovic, MD; and Timothy G. Murray, MD, MBA

Insights Into Lamellar Macular Holes

John T. Thompson, MD and Timothy G. Murray, MD, MBA, FASRS

Compound Interactions in Retina Surgery

Mario Romano, MD, PhD and R.V. Paul Chan, MD, MSc, MBA, FACS

Macular Holes and the Viscostretch Technique

Mrinali P. Gupta, MD and R.V. Paul Chan, MD, MSc, MBA, FACS

Back to All Videos

A TKI Update for Wet AMD

Carl D. Regillo, MD and R.V. Paul Chan, MD, MSc, MBA, FACS

Dr. Regillo shares data on several tyrosine kinase inhibitors in the pipeline for the treatment of wet AMD; a few are in phase 3 now.

Posted: 3/12/2025

Keywords:

retina-meeting-recap

•

TKI

•

tyrosine kinase inhibitor (TKI)

•

Wet AMD

•

Age-Related Macular Degeneration (AMD)

•

Clinical Trials

Please log in to leave a comment.

Meeting Coverage:

Aspen Retinal Detachment Society

A TKI Update for Wet AMD

Up Next

A TKI Update for Wet AMD

More From ARDS: 2025 Coverage